Eluxadoline
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Eluxadoline is used to treat irritable bowel syndrome, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on May 27, 2015, and the first generic was approved Mar 14, 2025. In 2024, Medicare Part D spent $59 million on Eluxadoline across 35,000 claims for 6,935 beneficiaries.
Eluxadoline is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $28.09 to $28.10 per EA — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$28.09 – $28.10
per EA
7d Activity
avg -0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Allergan, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing ELUXADOLINE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
VIBERZI 75 MG TABLET | $28.1038 per EA | -0.06% |
VIBERZI 100 MG TABLET | $28.0935 per EA | 0.00% |
Frequently Asked Questions
What is Eluxadoline used to treat?
Eluxadoline is used to treat irritable bowel syndrome, per the National Library of Medicine's MED-RT classification.
When did Eluxadoline become available as a generic?
FDA approved the first generic Eluxadoline (ANDA) on Mar 14, 2025.
How much does Medicare spend on Eluxadoline?
In 2024, Medicare Part D spent $59 million on Eluxadoline across 35,000 claims for 6,935 beneficiaries.
How many Eluxadoline products are on the market?
The Eluxadoline drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Eluxadoline?
NADAC reference prices for Eluxadoline range from $28.0935 to $28.1038 per EA — a 0% difference between cheapest and most expensive.
Which manufacturers make Eluxadoline?
1 manufacturer lists Eluxadoline in NADAC. Ranked by number of NDCs, the largest are Allergan, Inc. (2).
How has the price of Eluxadoline changed recently?
Over the past 7 days, 0 Eluxadoline NDCs rose and 1 fell, with a market-wide average change of -0.0%.